Stueland Katherine sold WGS
September 30, 2025 · Form 4 insider transaction
Stueland Katherine sold 200 shares of GeneDx Holdings Corp. at $110.23 per share, a transaction worth $22.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$110.23
Total value
$22.0K
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 30, 2025
Filing dateOctober 1, 2025
Shares owned after2,501
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024.